{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T01:02:25Z","timestamp":1774314145792,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T00:00:00Z","timestamp":1682035200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T00:00:00Z","timestamp":1682035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Justus-Liebig-Universit\u00e4t Gie\u00dfen"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologie"],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:sec>\n                <jats:title>Hintergrund<\/jats:title>\n                <jats:p>Die Fr\u00fchgeborenenretinopathie (\u201eretinopathy of prematurity\u201c [ROP]) z\u00e4hlt in Deutschland und weltweit zu den h\u00e4ufigsten Erblindungsursachen im Kindesalter; ein ad\u00e4quates Screening ist essenziell. Der telemedizinische Ansatz mit objektiver Dokumentation des Netzhautbefundes er\u00f6ffnet die M\u00f6glichkeit, untersucherunabh\u00e4ngig alle ROP-Stadien sicher zu diagnostizieren, wenn die Befundung durch ein ROP-geschultes Augen\u00e4rzteteam erfolgt.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Ziel der Arbeit<\/jats:title>\n                <jats:p>10-Jahres-Vergleich des ROP-Screenings an 2 deutschen Level-1-Perinatalzentren: universit\u00e4r und vor Ort vs. nichtuniversit\u00e4r und telemedizinisch.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Material und Methoden<\/jats:title>\n                <jats:p>Retrospektive Analyse der Screeninguntersuchungen stratifiziert nach Gestationsalter (GA), Geburtsgewicht (GG), Geschlecht, Mehrlingsgeburten, ROP-Zeitpunkt, Behandlungsbed\u00fcrftigkeit, -zeitpunkt und Untersuchungsh\u00e4ufigkeit.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Ergebnisse<\/jats:title>\n                <jats:p>Von 2009 bis 2019 wurden 1191 Fr\u00fchgeborene gescreent, davon 29\u00a0Externe. Bei den verbleibenden 1162 wurden 3713 Netzhautuntersuchungen durchgef\u00fchrt; 34\u202f% hatten eine ROP, 5,4\u202f% wurden behandelt (Gie\u00dfen 3,7\u202f%, Siegen 7,2\u202f%). Mittleres GA war 28,9\u00a0SSW (\u00b1\u202f2,5), mittleres GG 1155\u202fg (\u00b1\u202f417,5). Die Zahl der ROP-Diagnosen stieg in Gie\u00dfen um 227,3\u202f% und in Siegen um 111,1\u202f% aufgrund zunehmender Zahlen der betreuten Kinder.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Diskussion<\/jats:title>\n                <jats:p>Die vergleichende Analyse best\u00e4tigte national und international steigende ROP-Screening-Untersuchungen und Kinder mit akuter ROP. Das telemedizinische Screening war dem Vor-Ort-Screening gleichwertig und sicher. Mit beiden Screeningmethoden wurden alle Behandlungsbed\u00fcrftigen zeitgerecht erkannt. Kein Kind mit einem GA &gt;\u202f29\u00a0SSW ben\u00f6tigte eine Behandlung, analog zu Ergebnissen des schwedischen Registers. Im deutschen ROP-Register waren aber einzelne Fr\u00fchgeborene mit einem GA \u2265\u202f30\u00a0SSW behandlungsbed\u00fcrftig.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00347-023-01847-z","type":"journal-article","created":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T04:02:54Z","timestamp":1682049774000},"page":"920-931","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["10\u00a0Jahre Screening auf Fr\u00fchgeborenenretinopathie (2009\u20132019)","10\u00a0years of screening for retinopathy of prematurity (2009\u20132019)"],"prefix":"10.1007","volume":"120","author":[{"given":"Valentina","family":"Busik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9737-8127","authenticated-orcid":false,"given":"Birgit","family":"Lorenz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Mais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"J\u00e4ger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Friedburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Andrassi-Darida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harald","family":"Ehrhardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mechthild","family":"Hubert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,21]]},"reference":[{"issue":"12","key":"1847_CR1","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1055\/a-1012-1999","volume":"237","author":"M Andrassi-Darida","year":"2020","unstructured":"Andrassi-Darida\u00a0M, Mais\u00a0C, Stieger\u00a0K et al (2020) Fluoreszenzangiografieassistiertes Management von Rezidiven bei aggressiver posteriorer Fr\u00fchgeborenenretinopathie (APROP) nach intravitrealer Monotherapie mit 0,312\u202fmg Bevacizumab. Klin Monbl Augenheilkd 237(12):1468\u20131476. https:\/\/doi.org\/10.1055\/a-1012-1999","journal-title":"Klin Monbl Augenheilkd"},{"key":"1847_CR2","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s00347-021-01528-9","volume":"119","author":"SH Akman","year":"2022","unstructured":"Akman\u00a0SH, Pfeil\u00a0JM, Stahl\u00a0A et al (2022) Epidemiologie und Therapie der behandlungsbed\u00fcrftigen Fr\u00fchgeborenenretinopathie. Die Hannoveraner Daten im Retina.net ROP-Register von 2001 bis 2017. Ophthalmologe 119:497\u2013505. https:\/\/doi.org\/10.1007\/s00347-021-01528-9","journal-title":"Ophthalmologe"},{"issue":"3","key":"1847_CR3","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1001\/jamapediatrics.2014.3351","volume":"169","author":"PY Ancel","year":"2015","unstructured":"Ancel\u00a0PY, Goffinet\u00a0F, Kuhn\u00a0P et al (2015) Survival and morbidity of preterm children born at 22 through 34\u00a0weeks\u2019 gestation in france in 2011 results of the EPIPAGE\u20112 cohort study. JAMA Pediatr 169(3):230\u2013238. https:\/\/doi.org\/10.1001\/jamapediatrics.2014.3351","journal-title":"JAMA Pediatr"},{"issue":"5","key":"1847_CR4","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1001\/jamaophthalmol.2018.0649","volume":"136","author":"H Biten","year":"2018","unstructured":"Biten\u00a0H, Redd\u00a0TK, Moleta\u00a0C et\u00a0al (2018) Diagnostic accuracy of ophthalmoscopy vs telemedicine in examinations for retinopathy of prematurity. JAMA Ophthalmol 136(5):498\u2013504. https:\/\/doi.org\/10.1001\/jamaophthalmol.2018.0649","journal-title":"JAMA Ophthalmol"},{"key":"1847_CR5","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2018-3810","author":"WM Fierson","year":"2018","unstructured":"Fierson\u00a0WM, American Academy of Pediatrics Section on Ophthalmology, American Academy of Ophthalmology, American Association for Pediatric Ophthalmology and Strabismus, American Association of Certified Orthoptists (2018) Screening examination of premature infants for retinopathy of prematurity. Pediatrics. https:\/\/doi.org\/10.1542\/peds.2018-3810","journal-title":"Pediatrics"},{"key":"1847_CR6","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1136\/bjophthalmol-2019-314874","volume":"104","author":"G Holmstr\u00f6m","year":"2020","unstructured":"Holmstr\u00f6m\u00a0G, Hellstr\u00f6m\u00a0A, Gr\u00e4nse\u00a0L et al (2020) New modifications of Swedish ROP guidelines based on 10-year data from the SWEDROP register. Br J Ophthalmol 104:943\u2013949. https:\/\/doi.org\/10.1136\/bjophthalmol-2019-314874","journal-title":"Br J Ophthalmol"},{"key":"1847_CR7","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2015-307263","author":"G Holmstr\u00f6m","year":"2016","unstructured":"Holmstr\u00f6m\u00a0G, Hellstr\u00f6m\u00a0A, Jakobsson\u00a0P et\u00a0al (2016) Five years of treatment for retinopathy of prematurity in Sweden: results from SWEDROP, a\u00a0national quality register. Br J Ophthalmol. https:\/\/doi.org\/10.1136\/bjophthalmol-2015-307263","journal-title":"Br J Ophthalmol"},{"key":"1847_CR8","unstructured":"Institut f\u00fcr angewandte Qualit\u00e4tsf\u00f6rderung und Forschung im Gesundheitswesen (AQUA) Bundesauswertungen zu den Erfassungsjahren 2010, 2011, 2012, 2013 und 2014: Neonatologie. https:\/\/sqg.de\/front_content.php?idart=120. Zugegriffen: 1. Dez. 2022"},{"key":"1847_CR9","unstructured":"Institut f\u00fcr Qualit\u00e4tssicherung und Transparenz im Gesundheitswesen (IQTIG) Bundesauswertungen zu den Erfassungsjahren 2015, 2016, 2017, 2019, 2021: Neonatologie. https:\/\/iqtig.org\/qs-verfahren\/peri\/#analysis49. Zugegriffen: 1. Dez. 2022"},{"issue":"1","key":"1847_CR10","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s00347-007-1674-y","volume":"105","author":"C Jandeck","year":"2008","unstructured":"Jandeck\u00a0C, Kellner\u00a0U, Lorenz\u00a0B et al (2008) Leitlinie zur augen\u00e4rztlichen Screening-Untersuchung von Fr\u00fchgeborenen. Ophthalmologe 105(1):81\u201390. https:\/\/doi.org\/10.1007\/s00347-007-1674-y","journal-title":"Ophthalmologe"},{"key":"1847_CR11","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1093\/pch\/21.2.101","volume":"21","author":"AL Jefferies","year":"2016","unstructured":"Jefferies\u00a0AL, Canadian Paediatric Society, Fetus and Newborn Committee (2016) Retinopathy of prematurity: an update on screening and management. Paediatr Child Health 21:101\u2013104. https:\/\/doi.org\/10.1093\/pch\/21.2.101","journal-title":"Paediatr Child Health"},{"issue":"6","key":"1847_CR12","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.jaapos.2012.09.004","volume":"16","author":"L Kong","year":"2012","unstructured":"Kong\u00a0L, Fry\u00a0M, Al-Samarraie\u00a0M et al (2012) An update on progress and the changing epidemiology of causes of childhood blindness worldwide. J\u00a0AAPOS 16(6):501\u2013507. https:\/\/doi.org\/10.1016\/j.jaapos.2012.09.004","journal-title":"J AAPOS"},{"key":"1847_CR13","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s00347-018-0675-3","volume":"115","author":"PP Larsen","year":"2018","unstructured":"Larsen\u00a0PP, Br\u00fcnder\u00a0M\u2011C, Petrak\u00a0M et al (2018) Screening for retinopathy of prematurity: trends over the past 5\u00a0years in two German university hospitals. Ophthalmologe 115:469\u2013475. https:\/\/doi.org\/10.1007\/s00347-018-0675-3","journal-title":"Ophthalmologe"},{"key":"1847_CR14","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1136\/archdischild-2020-319767","volume":"106","author":"PP Larsen","year":"2021","unstructured":"Larsen\u00a0PP, M\u00fcller\u00a0A, Lagr\u00e8ze\u00a0WA et\u00a0al (2021) Incidence of retinopathy of prematurity in Germany:evaluation of current screening criteria. Arch Dis Child Fetal Neonatal Ed 106:189\u2013193. https:\/\/doi.org\/10.1136\/archdischild-2020-319767","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"1847_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s00347-021-01393-6","author":"JQ Li","year":"2021","unstructured":"Li\u00a0JQ, Kellner\u00a0U, Lorenz\u00a0B et\u00a0al (2021) Screening for retinopathy of prematurity\u2014the most important changes in the new German guidelines 2020. Ophthalmologe. https:\/\/doi.org\/10.1007\/s00347-021-01393-6","journal-title":"Ophthalmologe"},{"issue":"9","key":"1847_CR16","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1007\/s00417-009-1077-7","volume":"247","author":"B Lorenz","year":"2009","unstructured":"Lorenz\u00a0B, Spasovska\u00a0K, Elflein\u00a0H et al (2009) Wide-field digital imaging based telemedicine for screening for acute retinopathy of prematurity (ROP). Six-year results of a\u00a0multicentre field study. Graefes Arch Clin Exp Ophthalmol 247(9):1251\u20131262. https:\/\/doi.org\/10.1007\/s00417-009-1077-7","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1847_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/s00347-021-01353-0","author":"RF Maier","year":"2021","unstructured":"Maier\u00a0RF, Hummler\u00a0H, Kellner\u00a0U et al (2021) Augen\u00e4rztliche Screening-Untersuchung bei Fr\u00fchgeborenen (S2k-Level, AWMF-Leitlinien-Register-Nr.\u00a0024\/010, M\u00e4rz 2020). Ophthalmologe. https:\/\/doi.org\/10.1007\/s00347-021-01353-0","journal-title":"Ophthalmologe"},{"key":"1847_CR18","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1093\/pch\/21.2.101","volume":"96","author":"PS Muether","year":"2012","unstructured":"Muether\u00a0PS, Kribs\u00a0A, Hahn\u00a0M et al (2012) No advanced retinopathy of prematurity stages 4 or 5 in a\u00a0large high-risk German cohort. Br J Ophthalmol 96:400\u2013404. https:\/\/doi.org\/10.1093\/pch\/21.2.101","journal-title":"Br J Ophthalmol"},{"key":"1847_CR19","unstructured":"Nederlandse Oogheelkundig Gezelschap (NOG), Nederlandse Vereniging Kindergeneeskunde (NVK), Vereniging Ouders van Couveusekinderen (VOC). Richtlijn Prematurenretinopathie. www.nedrop.nl\/upload\/definitieve-roprichtlijn-juli-2012.pdf Zugegriffen: 1. Aug. 2022"},{"key":"1847_CR20","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1136\/bjophthalmol-2013-304493","volume":"98","author":"AJ van Sorge","year":"2014","unstructured":"van Sorge\u00a0AJ, Termote\u00a0JUM, Simonsz\u00a0HJ et\u00a0al (2014) Outcome and quality of screening in a\u00a0nationwide survey on retinopathy of prematurity in the Netherlands. Br J Ophthalmol 98:1056\u20131060. https:\/\/doi.org\/10.1136\/bjophthalmol-2013-304493","journal-title":"Br J Ophthalmol"},{"key":"1847_CR21","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2021-319929","author":"K Trzcionkowska","year":"2021","unstructured":"Trzcionkowska\u00a0K, Termote\u00a0JUM, B\u00f6hringer\u00a0S et\u00a0al (2021) Nationwide inventory on retinopathy of prematurity screening in the Netherlands. Br J Ophthalmol. https:\/\/doi.org\/10.1136\/bjophthalmol-2021-319929","journal-title":"Br J Ophthalmol"},{"key":"1847_CR22","doi-asserted-by":"publisher","DOI":"10.1111\/aos.13069","author":"JM Walz","year":"2016","unstructured":"Walz\u00a0JM, Bemme\u00a0S, Pielen\u00a0A et\u00a0al (2016) The German ROP Registry: data from 90 infants treated for retinopathy of prematurity. Acta Ophthalmol. https:\/\/doi.org\/10.1111\/aos.13069","journal-title":"Acta Ophthalmol"},{"key":"1847_CR23","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s00347-018-0701-5","volume":"115","author":"JM Walz","year":"2018","unstructured":"Walz\u00a0JM et al (2018) Treated cases of retinopathy of prematurity in Germany: 5\u2011year data from the Retina.net ROP registry. Ophthalmologe 115:476\u2013488. https:\/\/doi.org\/10.1007\/s00347-018-0701-5","journal-title":"Ophthalmologe"},{"key":"1847_CR24","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1093\/pch\/21.2.101","volume":"84","author":"AR Wilkinson","year":"2008","unstructured":"Wilkinson\u00a0AR, Haines\u00a0L, Head\u00a0K et\u00a0al (2008) UK retinopathy of prematurity guideline. Early Hum Dev 84:71\u201374. https:\/\/doi.org\/10.1093\/pch\/21.2.101","journal-title":"Early Hum Dev"}],"container-title":["Die Ophthalmologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-023-01847-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00347-023-01847-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-023-01847-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T14:02:21Z","timestamp":1693836141000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00347-023-01847-z"}},"subtitle":["Ergebnisanalyse zweier deutscher Level-1-Perinatalzentren mit universit\u00e4rem Vor-Ort-Screening und telemedizinischem Ansatz in dem nicht universit\u00e4ren Zentrum","Results analysis of two German level-1 neonatal intensive care units (NICUs) with university on-site screening and a\u00a0telemedical approach in the non-university NICU"],"short-title":[],"issued":{"date-parts":[[2023,4,21]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["1847"],"URL":"https:\/\/doi.org\/10.1007\/s00347-023-01847-z","relation":{},"ISSN":["2731-720X","2731-7218"],"issn-type":[{"value":"2731-720X","type":"print"},{"value":"2731-7218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,21]]},"assertion":[{"value":"20 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"V.\u00a0Busik, B.\u00a0Lorenz, C.\u00a0Mais, M.\u00a0J\u00e4ger, C.\u00a0Friedburg, M.\u00a0Andrassi-Darida, H.\u00a0Ehrhardt und M.\u00a0Hubert geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren. Bei diesem Beitrag handelt es sich um eine retrospektive Analyse von bereits erhobenen Basisdaten, augen\u00e4rztlichem Bildmaterial und Befunden ohne Einfluss auf die Behandlung der Studienteilnehmer. Es wurden keine Untersuchungen an Kindern f\u00fcr diese Studie durchgef\u00fchrt. Die Screeninguntersuchungen fanden im Zeitraum 2009 bis 2019 nicht f\u00fcr die Erstellung einer Studie statt, sondern erfolgten aus rein medizinischer Notwendigkeit, basierend auf den zum Zeitraum geltenden deutschen Leitlinien, um eine fr\u00fchzeitige Diagnostik der Fr\u00fchgeborenenretinopathie und einen rechtzeitigen Beginn einer Therapie zu erm\u00f6glichen und um somit eine fr\u00fchkindliche Erblindung zu verhindern. Die retrospektive Analyse ist eine wichtige Qualit\u00e4tskontrolle.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}